Experts calculate the global vaccine industry will be worth $52bn in 2016, more than double the total for 2009. The increased acceptance of adult vaccines, in conjunction with the growing focus on neglected diseases has highlighted the significant role vaccines play in the future of the pharmaceutical industry. Vaccine industry in Asian emerging markets such as China and India is contributing the majority of growth for the market thanks to the huge demand for technology transfer, scaling up, new facilities for multi-products, and also licensing rights for the access to novel vaccines and advanced biotech in Asia.
GEC Group is proud to present our World Vaccine Manufacturers China Summit 2014 ( www.wvmcs.com ), taking place on the 27th & 28th March 2014 at the Parkyard Hotel Shanghai. This event will offer vital insights into the core strategies and technologies shaping the future of world vaccines industry and is a must for anyone working in the field of vaccines.
The conference program consists of world-class keynote addresses, industry and academic led presentations and ample networking opportunities creating an interactive platform for high-level scientific and business discussions. We welcome you to reach out to us at 8621-65753313 or send you request to us via marketing@gecgroup.cn .